Literature DB >> 26315534

Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapy.

Leticia Corrales1, Thomas F Gajewski2.   

Abstract

Entities:  

Keywords:  STING pathway; Tumor immunology; Type I IFN

Mesh：

Substances：

Year:  2015        PMID： 26315534      PMCID： PMC4666728          DOI： 10.1016/j.cyto.2015.08.258

Source DB:  PubMed          Journal:  Cytokine        ISSN： 1043-4666            Impact factor:   3.861


× No keyword cloud information.
  10 in total

Review 1.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

2.  The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.

Authors:  Byron C Burnette; Hua Liang; Youjin Lee; Lukasz Chlewicki; Nikolai N Khodarev; Ralph R Weichselbaum; Yang-Xin Fu; Sogyong L Auh
Journal:  Cancer Res       Date:  2011-02-07       Impact factor: 12.701

3.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

Authors:  Liufu Deng; Hua Liang; Meng Xu; Xuanming Yang; Byron Burnette; Ainhoa Arina; Xiao-Dong Li; Helena Mauceri; Michael Beckett; Thomas Darga; Xiaona Huang; Thomas F Gajewski; Zhijian J Chen; Yang-Xin Fu; Ralph R Weichselbaum
Journal:  Immunity       Date:  2014-11-06       Impact factor: 31.745

4.  STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

Authors:  Seng-Ryong Woo; Mercedes B Fuertes; Leticia Corrales; Stefani Spranger; Michael J Furdyna; Michael Y K Leung; Ryan Duggan; Ying Wang; Glen N Barber; Katherine A Fitzgerald; Maria-Luisa Alegre; Thomas F Gajewski
Journal:  Immunity       Date:  2014-11-05       Impact factor: 31.745

5.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Authors:  Leticia Corrales; Laura Hix Glickman; Sarah M McWhirter; David B Kanne; Kelsey E Sivick; George E Katibah; Seng-Ryong Woo; Edward Lemmens; Tamara Banda; Justin J Leong; Ken Metchette; Thomas W Dubensky; Thomas F Gajewski
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

6.  Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.

Authors:  Lijun Sun; Jiaxi Wu; Fenghe Du; Xiang Chen; Zhijian J Chen
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

7.  Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

Authors:  Helena Harlin; Yuru Meng; Amy C Peterson; Yuanyuan Zha; Maria Tretiakova; Craig Slingluff; Mark McKee; Thomas F Gajewski
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

Review 8.  Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.

Authors:  Thomas F Gajewski; Seng-Ryong Woo; Yuanyuan Zha; Robbert Spaapen; Yan Zheng; Leticia Corrales; Stefani Spranger
Journal:  Curr Opin Immunol       Date:  2013-04-08       Impact factor: 7.486

9.  Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells.

Authors:  Mercedes B Fuertes; Aalok K Kacha; Justin Kline; Seng-Ryong Woo; David M Kranz; Kenneth M Murphy; Thomas F Gajewski
Journal:  J Exp Med       Date:  2011-09-19       Impact factor: 14.307

10.  Type I interferon is selectively required by dendritic cells for immune rejection of tumors.

Authors:  Mark S Diamond; Michelle Kinder; Hirokazu Matsushita; Mona Mashayekhi; Gavin P Dunn; Jessica M Archambault; Hsiaoju Lee; Cora D Arthur; J Michael White; Ulrich Kalinke; Kenneth M Murphy; Robert D Schreiber
Journal:  J Exp Med       Date:  2011-09-19       Impact factor: 14.307
  10 in total
  16 in total

1.  Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

Authors:  Jesse M Zaretsky; Angel Garcia-Diaz; Daniel S Shin; Helena Escuin-Ordinas; Willy Hugo; Siwen Hu-Lieskovan; Davis Y Torrejon; Gabriel Abril-Rodriguez; Salemiz Sandoval; Lucas Barthly; Justin Saco; Blanca Homet Moreno; Riccardo Mezzadra; Bartosz Chmielowski; Kathleen Ruchalski; I Peter Shintaku; Phillip J Sanchez; Cristina Puig-Saus; Grace Cherry; Elizabeth Seja; Xiangju Kong; Jia Pang; Beata Berent-Maoz; Begoña Comin-Anduix; Thomas G Graeber; Paul C Tumeh; Ton N M Schumacher; Roger S Lo; Antoni Ribas
Journal:  N Engl J Med       Date:  2016-07-13       Impact factor: 91.245

Review 2.  Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing.

Authors:  Qi Chen; Lijun Sun; Zhijian J Chen
Journal:  Nat Immunol       Date:  2016-09-20       Impact factor: 25.606

3.  cGAS is essential for the antitumor effect of immune checkpoint blockade.

Authors:  Hua Wang; Shuiqing Hu; Xiang Chen; Heping Shi; Chuo Chen; Lijun Sun; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

Review 4.  Myeloid neoplasms with germline DDX41 mutation.

Authors:  Jesse J C Cheah; Christopher N Hahn; Devendra K Hiwase; Hamish S Scott; Anna L Brown
Journal:  Int J Hematol       Date:  2017-05-25       Impact factor: 2.490

5.  Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity.

Authors:  Shruti P Raghunathan; Vanitha Raguveer; Prabhani U Atukorale; Taylor J Moon; Carolyn Zheng; Peter A Bielecki; Michelle L Wiese; Amy L Goldberg; Gil Covarrubias; Christopher J Hoimes; Efstathios Karathanasis
Journal:  Cancer Res       Date:  2019-08-20       Impact factor: 12.701

6.  Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity.

Authors:  Zachary T Morrow; Zachary M Powers; John-Demian Sauer
Journal:  Curr Clin Microbiol Rep       Date:  2019-11-20

7.  Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer.

Authors:  Gil Covarrubias; Taylor J Moon; Georgia Loutrianakis; Haley M Sims; Mayura P Umapathy; Morgan E Lorkowski; Peter A Bielecki; Michelle L Wiese; Prabhani U Atukorale; Efstathios Karathanasis
Journal:  J Mater Chem B       Date:  2022-01-05       Impact factor: 6.331

8.  Epithelial Cells in Endometriosis and Adenomyosis Upregulate STING Expression.

Authors:  Hong Qu; Lihong Li; Tian-Li Wang; Tamer Seckin; James Segars; Ie-Ming Shih
Journal:  Reprod Sci       Date:  2020-01-06       Impact factor: 3.060

9.  N-Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen-Presenting Cells through Dectin-1 and Dectin-2.

Authors:  Matthew N Zhou; Corleone S Delaveris; Jessica R Kramer; Justin A Kenkel; Edgar G Engleman; Carolyn R Bertozzi
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-21       Impact factor: 15.336

Review 10.  cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response.

Authors:  Debojit Bose
Journal:  Int J Mol Sci       Date:  2017-11-18       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.